D, C., M, P., M, R., M, Z., I, N., M, M., . . . F, P. (2022). CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors. La Radiologia medica, 127(7), 691. https://doi.org/10.1007/s11547-022-01506-4
Chicago Style (17th ed.) CitationD, Caruso, et al. "CT-based Radiomics for Prediction of Therapeutic Response to Everolimus in Metastatic Neuroendocrine Tumors." La Radiologia Medica 127, no. 7 (2022): 691. https://doi.org/10.1007/s11547-022-01506-4.
MLA (9th ed.) CitationD, Caruso, et al. "CT-based Radiomics for Prediction of Therapeutic Response to Everolimus in Metastatic Neuroendocrine Tumors." La Radiologia Medica, vol. 127, no. 7, 2022, p. 691, https://doi.org/10.1007/s11547-022-01506-4.